| Tyyppi : |
Lehti |
| Internet-yhteys : |
10.5863/1551-6776-25.8.723 |
|
| Tutkimus Joukkueet : |
Montreal - Faculté de pharmacie, Université de Montréal |
| Tekijät : |
Gillium C, Friciu M, Abatzoglou N, Leclair G. |
| Otsikko : |
Stability of Extemporaneously Prepared Acetazolamide Oral Suspensions at Two Temperatures. |
| Numero : |
J Pediatr Pharmacol Ther ;25, 8:723-729. 2020 |
|
| Todisteiden määrä : |
|
| Fyysinen vakaus : |
|
| Kemiallinen stabiilisuus : |
|
| Muut menetelmät : |
|
| Commentairesvaleur : |
|
Luettelo yhdisteistä
 Acetazolamide
|
 |
 |
 |
 |
750 mg
®=? (Pharma Inc) |
|
23-27°C |
 |
| 90 |
 |
|
|
|
|
 |
750 mg
|
|
23-27°C |
|
| 90 |
|
|
|
|
|
|
750 mg
|
|
23-27°C |
|
| 90 |
|
|
|
|
|
|
750 mg
®=? (Pharma Inc) |
|
23-27°C |
|
| 90 |
|
|
|
|
|
|
750 mg
®=? (Pharma Inc) |
|
3-7°C |
|
| 90 |
|
|
|
|
|
|
750 mg
|
|
3-7°C |
|
| 90 |
|
|
|
|
|
|
750 mg
|
|
3-7°C |
|
| 90 |
|
|
|
|
|
|
750 mg
®=? (Pharma Inc) |
|
3-7°C |
|
| 90 |
|
|
|
|
 |
|
25 mg
®=? (Pharma Inc) |
|
23-27°C |
|
| 90 |
|
|
|
|
|
|
25 mg
|
|
23-27°C |
|
| 90 |
|
|
|
|
|
|
25 mg
|
|
23-27°C |
|
| 90 |
|
|
|
|
|
|
25 mg
®=? (Pharma Inc) |
|
23-27°C |
|
| 90 |
|
|
|
|
|
|
25 mg
®=? (Pharma Inc) |
|
3-7°C |
|
| 90 |
|
|
|
|
|
|
25 mg
|
|
3-7°C |
|
| 90 |
|
|
|
|
|
|
25 mg
|
|
3-7°C |
|
| 90 |
|
|
|
|
|
|
25 mg
®=? (Pharma Inc) |
|
3-7°C |
|
| 90 |
|
|
|
|
|
